Companies / Sunesis Pharmaceuticals Inc
Sunesis Pharmaceuticals Inc
SNSSVIRXCIK 1061027
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Nov 29, 2021 | Royston Ivor CEO | Sell Open-market sale | Common Stock | $76.3K | -16K -2.70% | 571,289 | low |
| Nov 26, 2021 | Royston Ivor CEO | Sell Open-market sale | Common Stock | $57.2K | -12K -1.99% | 587,122 | low |
| Aug 26, 2022 | Royston Ivor CEO | Sell Open-market sale | Common Stock | $53.7K | -13K -2.14% | 612,770 | low |
| Nov 15, 2021 | Royston Ivor CEO | Buy Open-market buy | Common Stock | $44.5K | +8K +1.48% | 548,599 | low |
| May 11, 2021 | Rojkjaer Lisa Executive | Exercise Option exercise | Common Stock | $41.2K | +33K | 32,689 | low |
| Feb 28, 2022 | Royston Ivor CEO | Sell Open-market sale | Common Stock | $40.7K | -15K -2.43% | 588,873 | low |
| Feb 27, 2015 | Swisher Daniel N JR CEO | Other Withheld for taxes | Common Stock | $27.2K | -12K -6.53% | 175,824 | low |
| Nov 30, 2023 | Rothera Mark CEO | Buy Open-market buy | Common Stock | $25.7K | +52K | 52,094 | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| SNSS | common | 92765F108 |